nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—F2—malignant glioma	0.801	1	CbGaD
Dabigatran etexilate—F2—vertebral column—malignant glioma	0.00935	0.19	CbGeAlD
Dabigatran etexilate—Wound—Carmustine—malignant glioma	0.00873	0.133	CcSEcCtD
Dabigatran etexilate—F2—endothelium—malignant glioma	0.00416	0.0848	CbGeAlD
Dabigatran etexilate—F2—blood vessel—malignant glioma	0.00384	0.0782	CbGeAlD
Dabigatran etexilate—Haemorrhage intracranial—Temozolomide—malignant glioma	0.00298	0.0454	CcSEcCtD
Dabigatran etexilate—Cerebral haemorrhage—Carmustine—malignant glioma	0.00229	0.0348	CcSEcCtD
Dabigatran etexilate—CES2—retina—malignant glioma	0.00226	0.046	CbGeAlD
Dabigatran etexilate—Cerebral haemorrhage—Temozolomide—malignant glioma	0.00221	0.0336	CcSEcCtD
Dabigatran etexilate—NQO2—brainstem—malignant glioma	0.00209	0.0426	CbGeAlD
Dabigatran etexilate—Transaminases increased—Carmustine—malignant glioma	0.00208	0.0317	CcSEcCtD
Dabigatran etexilate—CES2—telencephalon—malignant glioma	0.00208	0.0423	CbGeAlD
Dabigatran etexilate—NQO2—telencephalon—malignant glioma	0.00185	0.0378	CbGeAlD
Dabigatran etexilate—Thrombosis—Carmustine—malignant glioma	0.00179	0.0272	CcSEcCtD
Dabigatran etexilate—CES2—medulla oblongata—malignant glioma	0.00163	0.0332	CbGeAlD
Dabigatran etexilate—CES2—midbrain—malignant glioma	0.00149	0.0304	CbGeAlD
Dabigatran etexilate—NQO2—medulla oblongata—malignant glioma	0.00146	0.0297	CbGeAlD
Dabigatran etexilate—CES2—spinal cord—malignant glioma	0.00145	0.0296	CbGeAlD
Dabigatran etexilate—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00135	0.0205	CcSEcCtD
Dabigatran etexilate—NQO2—midbrain—malignant glioma	0.00133	0.0271	CbGeAlD
Dabigatran etexilate—F2—spinal cord—malignant glioma	0.0013	0.0266	CbGeAlD
Dabigatran etexilate—NQO2—spinal cord—malignant glioma	0.0013	0.0265	CbGeAlD
Dabigatran etexilate—Hepatic enzyme increased—Temozolomide—malignant glioma	0.00129	0.0197	CcSEcCtD
Dabigatran etexilate—Musculoskeletal pain—Temozolomide—malignant glioma	0.00124	0.0188	CcSEcCtD
Dabigatran etexilate—CES2—central nervous system—malignant glioma	0.00118	0.024	CbGeAlD
Dabigatran etexilate—CES2—cerebellum—malignant glioma	0.00115	0.0235	CbGeAlD
Dabigatran etexilate—F2—central nervous system—malignant glioma	0.00106	0.0216	CbGeAlD
Dabigatran etexilate—NQO2—central nervous system—malignant glioma	0.00105	0.0215	CbGeAlD
Dabigatran etexilate—NQO2—cerebellum—malignant glioma	0.00103	0.021	CbGeAlD
Dabigatran etexilate—CES1—central nervous system—malignant glioma	0.000972	0.0198	CbGeAlD
Dabigatran etexilate—CES2—brain—malignant glioma	0.000937	0.0191	CbGeAlD
Dabigatran etexilate—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000919	0.014	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Carmustine—malignant glioma	0.000849	0.0129	CcSEcCtD
Dabigatran etexilate—F2—brain—malignant glioma	0.00084	0.0171	CbGeAlD
Dabigatran etexilate—NQO2—brain—malignant glioma	0.000837	0.017	CbGeAlD
Dabigatran etexilate—ABCB1—blood vessel—malignant glioma	0.000825	0.0168	CbGeAlD
Dabigatran etexilate—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0008	0.0122	CcSEcCtD
Dabigatran etexilate—Dysphagia—Carmustine—malignant glioma	0.000794	0.0121	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.000783	0.0119	CcSEcCtD
Dabigatran etexilate—CES1—brain—malignant glioma	0.000771	0.0157	CbGeAlD
Dabigatran etexilate—Dysphagia—Temozolomide—malignant glioma	0.000768	0.0117	CcSEcCtD
Dabigatran etexilate—Bronchitis—Temozolomide—malignant glioma	0.000738	0.0112	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Temozolomide—malignant glioma	0.000713	0.0109	CcSEcCtD
Dabigatran etexilate—Pneumonia—Carmustine—malignant glioma	0.000712	0.0108	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Carmustine—malignant glioma	0.000688	0.0105	CcSEcCtD
Dabigatran etexilate—Pneumonia—Temozolomide—malignant glioma	0.000688	0.0105	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Temozolomide—malignant glioma	0.000684	0.0104	CcSEcCtD
Dabigatran etexilate—Infestation—Temozolomide—malignant glioma	0.000684	0.0104	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Temozolomide—malignant glioma	0.000665	0.0101	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Temozolomide—malignant glioma	0.000647	0.00985	CcSEcCtD
Dabigatran etexilate—Sinusitis—Temozolomide—malignant glioma	0.000642	0.00977	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Carmustine—malignant glioma	0.000639	0.00972	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Carmustine—malignant glioma	0.000636	0.00967	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Carmustine—malignant glioma	0.000626	0.00953	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Carmustine—malignant glioma	0.000625	0.00951	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Temozolomide—malignant glioma	0.000618	0.0094	CcSEcCtD
Dabigatran etexilate—Haemorrhage—Temozolomide—malignant glioma	0.000614	0.00935	CcSEcCtD
Dabigatran etexilate—Urinary tract disorder—Temozolomide—malignant glioma	0.000607	0.00923	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Temozolomide—malignant glioma	0.000605	0.00921	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Temozolomide—malignant glioma	0.000604	0.00919	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Temozolomide—malignant glioma	0.000602	0.00916	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Temozolomide—malignant glioma	0.00057	0.00868	CcSEcCtD
Dabigatran etexilate—Angiopathy—Temozolomide—malignant glioma	0.000557	0.00848	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Temozolomide—malignant glioma	0.000555	0.00844	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Temozolomide—malignant glioma	0.000554	0.00843	CcSEcCtD
Dabigatran etexilate—Malnutrition—Carmustine—malignant glioma	0.000554	0.00842	CcSEcCtD
Dabigatran etexilate—Back pain—Carmustine—malignant glioma	0.000535	0.00815	CcSEcCtD
Dabigatran etexilate—Malnutrition—Temozolomide—malignant glioma	0.000535	0.00814	CcSEcCtD
Dabigatran etexilate—Back pain—Temozolomide—malignant glioma	0.000517	0.00787	CcSEcCtD
Dabigatran etexilate—Anaemia—Carmustine—malignant glioma	0.000512	0.00778	CcSEcCtD
Dabigatran etexilate—Anaemia—Temozolomide—malignant glioma	0.000494	0.00752	CcSEcCtD
Dabigatran etexilate—ABCB1—embryo—malignant glioma	0.000492	0.01	CbGeAlD
Dabigatran etexilate—Angioedema—Temozolomide—malignant glioma	0.000489	0.00744	CcSEcCtD
Dabigatran etexilate—Hypertension—Carmustine—malignant glioma	0.000478	0.00727	CcSEcCtD
Dabigatran etexilate—Palpitations—Temozolomide—malignant glioma	0.000473	0.00719	CcSEcCtD
Dabigatran etexilate—Chest pain—Carmustine—malignant glioma	0.000471	0.00717	CcSEcCtD
Dabigatran etexilate—Cough—Temozolomide—malignant glioma	0.000467	0.0071	CcSEcCtD
Dabigatran etexilate—Hypertension—Temozolomide—malignant glioma	0.000462	0.00703	CcSEcCtD
Dabigatran etexilate—Arthralgia—Temozolomide—malignant glioma	0.000455	0.00693	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000452	0.00688	CcSEcCtD
Dabigatran etexilate—Infection—Carmustine—malignant glioma	0.000449	0.00683	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Carmustine—malignant glioma	0.000442	0.00673	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Temozolomide—malignant glioma	0.000437	0.00664	CcSEcCtD
Dabigatran etexilate—ABCB1—retina—malignant glioma	0.000435	0.00886	CbGeAlD
Dabigatran etexilate—Infection—Temozolomide—malignant glioma	0.000434	0.0066	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Temozolomide—malignant glioma	0.000428	0.00651	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Temozolomide—malignant glioma	0.000427	0.0065	CcSEcCtD
Dabigatran etexilate—Skin disorder—Temozolomide—malignant glioma	0.000424	0.00645	CcSEcCtD
Dabigatran etexilate—Hypotension—Carmustine—malignant glioma	0.000422	0.00642	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000412	0.00626	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Carmustine—malignant glioma	0.000403	0.00613	CcSEcCtD
Dabigatran etexilate—ABCB1—telencephalon—malignant glioma	0.0004	0.00815	CbGeAlD
Dabigatran etexilate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000398	0.00605	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Carmustine—malignant glioma	0.00039	0.00593	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Temozolomide—malignant glioma	0.000389	0.00592	CcSEcCtD
Dabigatran etexilate—Constipation—Carmustine—malignant glioma	0.000386	0.00588	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Temozolomide—malignant glioma	0.000384	0.00585	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000377	0.00573	CcSEcCtD
Dabigatran etexilate—Fatigue—Temozolomide—malignant glioma	0.000376	0.00573	CcSEcCtD
Dabigatran etexilate—Constipation—Temozolomide—malignant glioma	0.000373	0.00568	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Carmustine—malignant glioma	0.000369	0.00562	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Carmustine—malignant glioma	0.000357	0.00543	CcSEcCtD
Dabigatran etexilate—Gastrointestinal pain—Temozolomide—malignant glioma	0.000357	0.00543	CcSEcCtD
Dabigatran etexilate—Urticaria—Temozolomide—malignant glioma	0.000347	0.00528	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Temozolomide—malignant glioma	0.000345	0.00525	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Carmustine—malignant glioma	0.000333	0.00506	CcSEcCtD
Dabigatran etexilate—Asthenia—Carmustine—malignant glioma	0.000324	0.00493	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Temozolomide—malignant glioma	0.000322	0.00489	CcSEcCtD
Dabigatran etexilate—ABCB1—medulla oblongata—malignant glioma	0.000315	0.00641	CbGeAlD
Dabigatran etexilate—Asthenia—Temozolomide—malignant glioma	0.000313	0.00477	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Carmustine—malignant glioma	0.000309	0.0047	CcSEcCtD
Dabigatran etexilate—Pruritus—Temozolomide—malignant glioma	0.000309	0.0047	CcSEcCtD
Dabigatran etexilate—Dizziness—Carmustine—malignant glioma	0.000299	0.00454	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Temozolomide—malignant glioma	0.000299	0.00454	CcSEcCtD
Dabigatran etexilate—Dizziness—Temozolomide—malignant glioma	0.000289	0.00439	CcSEcCtD
Dabigatran etexilate—ABCB1—midbrain—malignant glioma	0.000288	0.00586	CbGeAlD
Dabigatran etexilate—Vomiting—Carmustine—malignant glioma	0.000287	0.00437	CcSEcCtD
Dabigatran etexilate—Rash—Carmustine—malignant glioma	0.000285	0.00433	CcSEcCtD
Dabigatran etexilate—Dermatitis—Carmustine—malignant glioma	0.000285	0.00433	CcSEcCtD
Dabigatran etexilate—Headache—Carmustine—malignant glioma	0.000283	0.00431	CcSEcCtD
Dabigatran etexilate—ABCB1—spinal cord—malignant glioma	0.00028	0.00571	CbGeAlD
Dabigatran etexilate—Vomiting—Temozolomide—malignant glioma	0.000278	0.00422	CcSEcCtD
Dabigatran etexilate—Rash—Temozolomide—malignant glioma	0.000275	0.00419	CcSEcCtD
Dabigatran etexilate—Dermatitis—Temozolomide—malignant glioma	0.000275	0.00418	CcSEcCtD
Dabigatran etexilate—Headache—Temozolomide—malignant glioma	0.000273	0.00416	CcSEcCtD
Dabigatran etexilate—Nausea—Carmustine—malignant glioma	0.000268	0.00408	CcSEcCtD
Dabigatran etexilate—Nausea—Temozolomide—malignant glioma	0.000259	0.00395	CcSEcCtD
Dabigatran etexilate—ABCB1—central nervous system—malignant glioma	0.000228	0.00463	CbGeAlD
Dabigatran etexilate—ABCB1—cerebellum—malignant glioma	0.000222	0.00453	CbGeAlD
Dabigatran etexilate—ABCB1—brain—malignant glioma	0.000181	0.00368	CbGeAlD
Dabigatran etexilate—F2—Signaling Pathways—MDK—malignant glioma	6.08e-05	0.000726	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	6.04e-05	0.000721	CbGpPWpGaD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—PIK3CA—malignant glioma	5.9e-05	0.000705	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—malignant glioma	5.89e-05	0.000703	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCR3—malignant glioma	5.84e-05	0.000697	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—BCAN—malignant glioma	5.81e-05	0.000694	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—RTEL1—malignant glioma	5.8e-05	0.000693	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DTX1—malignant glioma	5.8e-05	0.000692	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GSTP1—malignant glioma	5.78e-05	0.000691	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IFNG—malignant glioma	5.78e-05	0.00069	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—IDH2—malignant glioma	5.76e-05	0.000688	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—ATP1B2—malignant glioma	5.69e-05	0.00068	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CAT—malignant glioma	5.63e-05	0.000672	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	5.55e-05	0.000663	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—APOD—malignant glioma	5.54e-05	0.000661	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	5.51e-05	0.000659	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PDGFB—malignant glioma	5.51e-05	0.000658	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP2B6—malignant glioma	5.42e-05	0.000647	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CXCL8—malignant glioma	5.37e-05	0.000642	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—BDKRB2—malignant glioma	5.34e-05	0.000638	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—NCOR1—malignant glioma	5.31e-05	0.000635	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCR3—malignant glioma	5.3e-05	0.000633	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—CAV1—malignant glioma	5.22e-05	0.000623	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	5.16e-05	0.000616	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL1B—malignant glioma	5.16e-05	0.000616	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—CASP3—malignant glioma	5.14e-05	0.000614	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	5.14e-05	0.000614	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—IL2—malignant glioma	5.14e-05	0.000614	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	5.11e-05	0.000611	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	5.07e-05	0.000606	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—VEGFA—malignant glioma	5.04e-05	0.000602	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—FN1—malignant glioma	4.97e-05	0.000593	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—IDH1—malignant glioma	4.96e-05	0.000592	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—PIK3CA—malignant glioma	4.92e-05	0.000588	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—KNG1—malignant glioma	4.86e-05	0.00058	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—BDKRB2—malignant glioma	4.85e-05	0.000579	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SPHK1—malignant glioma	4.8e-05	0.000573	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	4.79e-05	0.000572	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PIK3CG—malignant glioma	4.75e-05	0.000568	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP2C18—malignant glioma	4.7e-05	0.000561	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—EGF—malignant glioma	4.7e-05	0.000561	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—IDH2—malignant glioma	4.68e-05	0.000559	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PTPN11—malignant glioma	4.67e-05	0.000558	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	4.65e-05	0.000555	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SUFU—malignant glioma	4.61e-05	0.00055	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HEY2—malignant glioma	4.55e-05	0.000543	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—GFAP—malignant glioma	4.44e-05	0.000531	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	4.42e-05	0.000527	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—KNG1—malignant glioma	4.41e-05	0.000527	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2B6—malignant glioma	4.4e-05	0.000526	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	4.4e-05	0.000526	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—VEGFA—malignant glioma	4.37e-05	0.000521	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT2—malignant glioma	4.35e-05	0.000519	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CAV1—malignant glioma	4.33e-05	0.000517	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	4.31e-05	0.000514	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SPHK1—malignant glioma	4.3e-05	0.000514	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HEY1—malignant glioma	4.21e-05	0.000503	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CCR4—malignant glioma	4.21e-05	0.000503	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PIK3CD—malignant glioma	4.18e-05	0.000499	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	4.15e-05	0.000496	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HIST1H3B—malignant glioma	4.09e-05	0.000489	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—IDH1—malignant glioma	4.03e-05	0.000481	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PIK3CG—malignant glioma	3.95e-05	0.000471	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CXCL8—malignant glioma	3.91e-05	0.000467	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—MMP3—malignant glioma	3.91e-05	0.000467	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SPHK1—malignant glioma	3.9e-05	0.000465	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2C18—malignant glioma	3.82e-05	0.000456	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PPARG—malignant glioma	3.81e-05	0.000455	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTT1—malignant glioma	3.8e-05	0.000454	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Allograft Rejection—TNF—malignant glioma	3.74e-05	0.000447	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—JAG2—malignant glioma	3.74e-05	0.000446	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—RAF1—malignant glioma	3.73e-05	0.000446	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	3.72e-05	0.000444	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PIK3CB—malignant glioma	3.64e-05	0.000435	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	3.6e-05	0.00043	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.6e-05	0.00043	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	3.56e-05	0.000425	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS1—malignant glioma	3.56e-05	0.000425	CbGpPWpGaD
Dabigatran etexilate—F2—Platelet activation, signaling and aggregation—AKT1—malignant glioma	3.52e-05	0.00042	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PIK3CD—malignant glioma	3.47e-05	0.000414	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—IL2—malignant glioma	3.34e-05	0.000399	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—COX8A—malignant glioma	3.33e-05	0.000398	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—MMP2—malignant glioma	3.31e-05	0.000396	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—BCHE—malignant glioma	3.31e-05	0.000395	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	3.28e-05	0.000392	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—SLC5A5—malignant glioma	3.27e-05	0.000391	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—AKT1—malignant glioma	3.22e-05	0.000384	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	3.16e-05	0.000378	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—H3F3A—malignant glioma	3.16e-05	0.000378	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCR3—malignant glioma	3.13e-05	0.000374	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTT1—malignant glioma	3.09e-05	0.000369	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NTRK2—malignant glioma	3.05e-05	0.000364	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—YWHAE—malignant glioma	3.05e-05	0.000364	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	3.03e-05	0.000362	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FLT1—malignant glioma	3.03e-05	0.000362	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PIK3CB—malignant glioma	3.02e-05	0.000361	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DUSP6—malignant glioma	3.02e-05	0.000361	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3CG—malignant glioma	3e-05	0.000359	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTGS2—malignant glioma	3e-05	0.000358	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—JAG1—malignant glioma	2.98e-05	0.000356	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOTCH3—malignant glioma	2.97e-05	0.000354	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FBXW7—malignant glioma	2.92e-05	0.000349	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS1—malignant glioma	2.89e-05	0.000346	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.88e-05	0.000344	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	2.88e-05	0.000344	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BDKRB2—malignant glioma	2.86e-05	0.000342	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—VEGFA—malignant glioma	2.84e-05	0.000339	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	2.84e-05	0.000339	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ASMT—malignant glioma	2.83e-05	0.000339	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—TFRC—malignant glioma	2.83e-05	0.000338	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	2.83e-05	0.000338	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	2.8e-05	0.000334	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—CXCL8—malignant glioma	2.75e-05	0.000329	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT2—malignant glioma	2.75e-05	0.000328	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	2.73e-05	0.000327	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3CG—malignant glioma	2.73e-05	0.000326	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—BCHE—malignant glioma	2.69e-05	0.000321	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PTPN11—malignant glioma	2.68e-05	0.00032	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—BCAN—malignant glioma	2.67e-05	0.000318	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOTCH2—malignant glioma	2.66e-05	0.000318	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—SLC5A5—malignant glioma	2.66e-05	0.000317	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3CD—malignant glioma	2.64e-05	0.000315	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GSTP1—malignant glioma	2.63e-05	0.000315	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PTEN—malignant glioma	2.61e-05	0.000312	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KNG1—malignant glioma	2.6e-05	0.000311	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.6e-05	0.000311	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CAT—malignant glioma	2.56e-05	0.000306	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	2.54e-05	0.000303	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.51e-05	0.0003	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT2—malignant glioma	2.5e-05	0.000298	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.49e-05	0.000297	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NTRK1—malignant glioma	2.48e-05	0.000297	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.48e-05	0.000296	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—NCOR1—malignant glioma	2.42e-05	0.000289	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—KRAS—malignant glioma	2.42e-05	0.000289	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3CD—malignant glioma	2.4e-05	0.000286	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	2.39e-05	0.000285	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP3—malignant glioma	2.31e-05	0.000276	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3CB—malignant glioma	2.3e-05	0.000275	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CDKN2B—malignant glioma	2.29e-05	0.000273	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTK2—malignant glioma	2.22e-05	0.000265	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—PIK3CA—malignant glioma	2.22e-05	0.000265	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CXCL8—malignant glioma	2.21e-05	0.000264	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HES1—malignant glioma	2.18e-05	0.000261	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	2.17e-05	0.000259	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NCOR1—malignant glioma	2.17e-05	0.000259	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	2.15e-05	0.000257	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—IDH2—malignant glioma	2.15e-05	0.000257	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—TP53—malignant glioma	2.15e-05	0.000257	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—RAF1—malignant glioma	2.14e-05	0.000256	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GSTP1—malignant glioma	2.14e-05	0.000256	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—IL2—malignant glioma	2.11e-05	0.000252	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3CB—malignant glioma	2.09e-05	0.00025	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CAT—malignant glioma	2.08e-05	0.000249	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDGFRA—malignant glioma	2.08e-05	0.000248	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2B6—malignant glioma	2.02e-05	0.000241	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—SPP1—malignant glioma	2.02e-05	0.000241	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CXCL8—malignant glioma	2.01e-05	0.00024	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	1.98e-05	0.000237	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CAV1—malignant glioma	1.97e-05	0.000236	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—NCOR1—malignant glioma	1.97e-05	0.000235	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	1.94e-05	0.000232	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—IL2—malignant glioma	1.92e-05	0.000229	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TERT—malignant glioma	1.91e-05	0.000228	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDGFB—malignant glioma	1.87e-05	0.000223	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FGFR1—malignant glioma	1.86e-05	0.000222	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—IDH1—malignant glioma	1.85e-05	0.000221	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	1.85e-05	0.000221	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—PIK3CA—malignant glioma	1.84e-05	0.00022	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	1.83e-05	0.000219	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HIF1A—malignant glioma	1.83e-05	0.000218	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—AKT1—malignant glioma	1.81e-05	0.000217	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CG—malignant glioma	1.8e-05	0.000215	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SPHK1—malignant glioma	1.79e-05	0.000214	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CAV1—malignant glioma	1.77e-05	0.000211	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2C18—malignant glioma	1.75e-05	0.000209	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KDR—malignant glioma	1.75e-05	0.000209	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PPARG—malignant glioma	1.73e-05	0.000207	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FN1—malignant glioma	1.68e-05	0.000201	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	1.68e-05	0.000201	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BAD—malignant glioma	1.66e-05	0.000199	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NOTCH1—malignant glioma	1.65e-05	0.000197	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	1.63e-05	0.000194	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CD80—malignant glioma	1.61e-05	0.000193	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—APC—malignant glioma	1.61e-05	0.000192	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CG—malignant glioma	1.61e-05	0.000192	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CAV1—malignant glioma	1.6e-05	0.000191	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EGF—malignant glioma	1.59e-05	0.00019	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTPN11—malignant glioma	1.58e-05	0.000189	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CD—malignant glioma	1.58e-05	0.000189	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.53e-05	0.000183	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—BRAF—malignant glioma	1.51e-05	0.000181	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—AKT1—malignant glioma	1.51e-05	0.00018	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT2—malignant glioma	1.47e-05	0.000176	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—EGFR—malignant glioma	1.47e-05	0.000175	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CG—malignant glioma	1.46e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CD—malignant glioma	1.42e-05	0.000169	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTT1—malignant glioma	1.42e-05	0.000169	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PPARG—malignant glioma	1.41e-05	0.000168	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PIK3CA—malignant glioma	1.4e-05	0.000168	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—KRAS—malignant glioma	1.39e-05	0.000166	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CB—malignant glioma	1.38e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	1.37e-05	0.000164	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTGS2—malignant glioma	1.36e-05	0.000163	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—FGF2—malignant glioma	1.36e-05	0.000162	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS1—malignant glioma	1.33e-05	0.000159	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CD—malignant glioma	1.28e-05	0.000153	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PIK3CA—malignant glioma	1.27e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MDM2—malignant glioma	1.27e-05	0.000152	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—RAF1—malignant glioma	1.26e-05	0.000151	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—ERBB2—malignant glioma	1.25e-05	0.000149	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CB—malignant glioma	1.23e-05	0.000147	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—BCHE—malignant glioma	1.23e-05	0.000147	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—SLC5A5—malignant glioma	1.22e-05	0.000146	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PTEN—malignant glioma	1.19e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CXCL8—malignant glioma	1.19e-05	0.000142	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AKT1—malignant glioma	1.15e-05	0.000137	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CASP3—malignant glioma	1.14e-05	0.000136	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—IL2—malignant glioma	1.13e-05	0.000135	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	1.12e-05	0.000134	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CB—malignant glioma	1.12e-05	0.000134	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTGS2—malignant glioma	1.11e-05	0.000132	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MMP9—malignant glioma	1.07e-05	0.000128	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PTEN—malignant glioma	1.07e-05	0.000127	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AKT1—malignant glioma	1.04e-05	0.000124	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GSTP1—malignant glioma	9.82e-06	0.000117	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PTEN—malignant glioma	9.67e-06	0.000115	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—VEGFA—malignant glioma	9.64e-06	0.000115	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CAT—malignant glioma	9.55e-06	0.000114	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—STAT3—malignant glioma	9.54e-06	0.000114	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—NCOR1—malignant glioma	9.02e-06	0.000108	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—MYC—malignant glioma	8.87e-06	0.000106	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EGFR—malignant glioma	8.67e-06	0.000104	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—PIK3CA—malignant glioma	8.39e-06	0.0001	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—KRAS—malignant glioma	8.19e-06	9.78e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PIK3CA—malignant glioma	7.53e-06	8.99e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CAV1—malignant glioma	7.35e-06	8.78e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—TP53—malignant glioma	7.28e-06	8.7e-05	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—AKT1—malignant glioma	6.86e-06	8.19e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—PIK3CA—malignant glioma	6.82e-06	8.15e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CG—malignant glioma	6.7e-06	8e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PPARG—malignant glioma	6.47e-06	7.72e-05	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AKT1—malignant glioma	6.15e-06	7.34e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CD—malignant glioma	5.89e-06	7.03e-05	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—AKT1—malignant glioma	5.57e-06	6.66e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CB—malignant glioma	5.13e-06	6.13e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTGS2—malignant glioma	5.09e-06	6.08e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PTEN—malignant glioma	4.44e-06	5.3e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—PIK3CA—malignant glioma	3.13e-06	3.74e-05	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—AKT1—malignant glioma	2.56e-06	3.05e-05	CbGpPWpGaD
